-The Hindu Obesity among children due to rampant consumption of junk food has reached epidemic proportions. With India already in the grip of this dangerous global trend, the government needs to remove its blinkers on the processed food industry One of the first declarations of the newly elected government in June was a proposal to ban unhealthy or junk food (defined as food high on fat, sugar and salt) in school...
More »SEARCH RESULT
Total Matching Records found : 791
Corruption in Indian Medicine Or ‘Overenthusiasm of the Marketing Department -Sanjay Nagral
-Economic and Political Weekly Corruption in Indian medicine is back on the front pages. One would think that there has been an abrupt spurt in corrupt practices or a major scandal. Nothing of that sort has happened. However, there have been some interesting developments for the focus to shift back to what is really a very old affliction. This is an update on recent happenings as the entrepreneurial spirit of the...
More »Bills in crores, Rs 2 lakh marked for patients -Durgesh Nandan Jha
-The Times of India NEW DELHI: Two super-speciality hospitals in the capital have not admitted any patient but auditors point out that both have already spent crores in maintenance. In 2011-12, Rajiv Gandhi Super-Speciality (RGSS) hospital had spent Rs 4.83 crore out of a budget allocation of Rs 5 crore. The following year, the allocation was increased to Rs 6 crore even though the expenditure on medical treatment remained the same -...
More »Major diabetes, cardiac drugs to become up to 35% cheaper -Rupali Mukherjee
-The Times of India MUMBAI: In a move that has surprised and shaken the industry, prices of widely-used expensive anti-diabetic and cardiac medicines will reduce by as much as 35% over the next few weeks, with the drug pricing regulator, National Pharmaceutical Pricing Authority (NPPA), deciding to bring them under price control. In a rare invocation of a lesser-used provision in the Drug Price Control Order (DPCO), NPPA has fixed the prices...
More »Pharma pricing norms set to be tightened -Sushmi Dey
-The Business Standard Regulator studying pricing models in various nations; draft legislation likely by end of March Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries. The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market,...
More »
